Re: [CANSLIM] ACDO, SRA

From: "Patrick Wahl" <pjwahl@attbi.com>
Subject: Re: [CANSLIM] ACDO, SRA
Date: Fri, 8 Mar 2002 13:19:03 -0700

Next Article (by Date): [CANSLIM] Andersen defections and Worley's Weekend Review "Duke Miller"
Previous Article (by Date): [CANSLIM] A chuckle for you "Tim Fisher"
Articles sorted by: [Date] [Author] [Subject]

I'm thinking you meant an RS of 28 and EPS of 32.  Not good numbers from DGO 
or Quotes Plus.

On 8 Mar 2002 at 14:56, Tom Worley wrote:

> DGO is putting SRA at an EPS of 28 including today's huge gap up. EPS is at
> 32
> 
> Tom Worley
> stkguru@netside.net
> AIM: TexWorley
> ----- Original Message -----
> From: "Patrick Wahl" <pjwahl@attbi.com>
> To: <canslim@lists.xmission.com>
> Sent: Friday, March 08, 2002 2:11 PM
> Subject: RE: [CANSLIM] ACDO, SRA
> 
> 
> According to Quotes Plus, earnings have fallen off from a couple bucks a
> share per
> quarter to the 10 to 16 cents per share range over the last 4 quarters.
> Their EPS
> number is 6, RS is 35
> 
> On 8 Mar 2002 at 10:53, Tim Fisher wrote:
> 
> > Actually, I meant EPS/RS/GRS etc....
> >
> > At 10:50 AM 3/8/2002 -0800, you wrote:
> > >[From Yahoo]
> > >Serono S.A., headquartered in Geneva, Switzerland, is a global
> > >biotechnology company with six recombinant products on the market:
> > >Gonal-F, Luveris, Ovidrel/Ovitrelle, Rebif, Serostim and Saizen (Rebif
> and
> > >Luveris are not approved in the United States). In addition to
> > >reproductive health, Serono has strong market positions in neurology,
> > >metabolism and growth. The Company's research programs are focused on
> > >growing these businesses and on establishing new therapeutic areas.
> > >Currently, there are 15 new molecules in development. The Company
> operates
> > >in 45 countries, and its products are sold in over 100 countries.
> > >More from Market Guide:
> > >
> > >
> > > > -----Original Message-----
> > > > From: owner-canslim@lists.xmission.com
> > > >
> > >
> [<mailto:owner-canslim@lists.xmission.com>mailto:owner-canslim@lists.xmissio
> n.com]On
> > > Behalf Of Tim Fisher
> > > > Sent: Friday, March 08, 2002 9:46 AM
> > > > To: canslim@mail.xmission.com
> > > > Subject: [CANSLIM] ACDO, SRA
> > > >
> > > >
> > > > Noticed the reason for ACDO's tumble this AM was SRA got approval for
> a
> > > > drug that has a different distributor. Anyone know anything about SRA?
> It
> > > > doesn't show up in my scans...
> > > >
> > > >
> > > > Tim Fisher
> >
> > Tim Fisher
> > Ore-ROCK-On Rockhounding Web Site
> > Owner, Fisher Fisheries, Ltd.
> > mailto:tim@OreRockOn.com
> > WWW http://OreRockOn.com
> >
> >
> > -
> > -To subscribe/unsubscribe, email "majordomo@xmission.com"
> > -In the email body, write "subscribe canslim" or
> > -"unsubscribe canslim".  Do not use quotes in your email.
> 
> 
> 
> -
> -To subscribe/unsubscribe, email "majordomo@xmission.com"
> -In the email body, write "subscribe canslim" or
> -"unsubscribe canslim".  Do not use quotes in your email.
> 
> 
> 
> 
> 
> -
> -To subscribe/unsubscribe, email "majordomo@xmission.com"
> -In the email body, write "subscribe canslim" or
> -"unsubscribe canslim".  Do not use quotes in your email.



- -
- -To subscribe/unsubscribe, email "majordomo@xmission.com"
- -In the email body, write "subscribe canslim" or
- -"unsubscribe canslim".  Do not use quotes in your email.

Go to Jeff Salisbury LWGate Home Page.